Nkarta Inc (NKTX)

Nkarta Inc (NKTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $161M; returns 1 day +2.9%, 1 week -0.6%, 1 year -20.8%.

Nkarta Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company's core focus has strategically shifted from oncology to severe autoimmune diseases, aiming to leverage the innate tumor-killing properties of NK cells for broader therapeutic application.

Groups NKTX belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Clinical Stage
• Healthcare
• Life Sciences
• Autoimmune Diseases
• Oncology

NKTX financial model: income statement, cash flow and balance sheet